Emmaus Life Sciences Commercial Co-Payment Assistance Program for Endari
Emmaus Life Sciences
OpenVerified·Apr 25, 2026
- Covers
- financial assistance
- Enrollment cycle
- rolling
Eligibility
This program provides financial assistance to commercially insured patients aged five and older who are prescribed Endari for sickle cell disease. Applicants must meet undisclosed financial eligibility requirements and submit a Patient Financial Assistance Application.
Apply
Application goes directly to Emmaus Life Sciences. RxCopays does not receive compensation.
Go to application →Status source
The application is available at pharmacies participating in the Endari Pharmacy Network and via the EndariRx.com website.
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: